Publication of Suppl.Prospcts

RNS Number : 4866F
Maven Income and Growth VCT 3 PLC
21 March 2022
 

Joint Announcement

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC (the "Companies")

Issue of Supplementary Prospectus

The Boards of the Companies today announce that they have published a supplementary prospectus (the "Supplementary Prospectus") relating to the offers for subscription issued by the Companies, details of which were set out in their prospectus (comprising a securities note, registration document and summary) issued on 20 September 2021.

The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of Financial Services and Market Act 2000 following the publication by Maven Income and Growth VCT 3 PLC on 7 March 2022 of its Annual Report and Financial Statements for the year ended 30 November 2021.

 

The Supplementary Prospectus has been approved by the Financial Conduct Authority, and copies will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism, and are available free of charge from the office of the investment manager of the Companies, Maven Capital Partners UK LLP, at Kintyre House, 205 West George Street, Glasgow G2 2LW and from the website of Maven Capital Partners UK LLP at: www.mavencp.com/vctoffer.

Enquiries

For further information, please contact:

Maven Capital Partners UK LLP

Tel: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLP

Secretary

21 March 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPPPUMAWUPPGCG
UK 100